Cargando…
Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study
PURPOSE: To establish an effective and accurate prognostic nomogram for lung adenocarcinoma (LUAD). Patients and Methods. 62,355 LUAD patients from 1975 to 2016 enrolled in the Surveillance, Epidemiology, and End Results (SEER) database were randomly and equally divided into the training cohort (n =...
Autores principales: | Xie, Bin, Chen, Xi, Deng, Qi, Shi, Ke, Xiao, Jian, Zou, Yong, Yang, Baishuang, Guan, Anqi, Yang, Shasha, Dai, Ziyu, Xie, Huayan, He, Shuya, Chen, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759395/ https://www.ncbi.nlm.nih.gov/pubmed/36536690 http://dx.doi.org/10.1155/2022/5698582 |
Ejemplares similares
-
Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021) -
Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023) -
Benzo(a)pyrene enhances the EMT-associated migration of lung adenocarcinoma A549 cells by upregulating Twist1
por: Chen, Xi, et al.
Publicado: (2017) -
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
por: Liu, Aibin, et al.
Publicado: (2021) -
Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)